Latest update:
Monday, May 9, 2016 - 17:27
19 May 2015
Sopharma AD informs that today Sopharma reached an agreement for the sale of 75% of the capital of Extab Corporation. After the transaction Sophama will remain a shareholder in the company with 5%.